Abstract
Immune tolerance fails in autoimmune polyendocrine syndrome type 1 (APS-1) because of AIRE mutations. We have used single cell transcriptomics to characterize regulatory T cells (Tregs) sorted directly from blood and from in vitro expanded Tregs in APS-1 patients compared to healthy controls. We revealed only CD52 and LTB (down) and TXNIP (up) as consistently differentially expressed genes in the datasets. There were furthermore no large differences of the TCR-repertoire of expanded Tregs between the cohorts, but unique patients showed a more restricted use of specific clonotypes. We also found that in vitro expanded Tregs from APS-1 patients had similar suppressive capacity as controls in co-culture assays, despite expanding faster and having more exhausted cells. Our results suggest that APS-1 patients do not have intrinsic defects in their Treg functionality, and that their Tregs can be expanded ex vivo for potential therapeutic applications.
| Original language | English |
|---|---|
| Article number | 109610 |
| Journal | iScience |
| Volume | 27 |
| Issue number | 4 |
| Number of pages | 23 |
| ISSN | 2589-0042 |
| DOIs | |
| Publication status | Published - 19 Apr 2024 |
| MoE publication type | A1 Journal article-refereed |
Bibliographical note
Publisher Copyright:© 2024 The Author(s)
Fields of Science
- Components of the immune system
- Health sciences
- Immunology
- Proteomics
- Transcriptomics
- 3121 General medicine, internal medicine and other clinical medicine
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver